DE69230890D1 - Bestimmung von nukleären matrixproteinen in flüssigkeiten - Google Patents

Bestimmung von nukleären matrixproteinen in flüssigkeiten

Info

Publication number
DE69230890D1
DE69230890D1 DE69230890T DE69230890T DE69230890D1 DE 69230890 D1 DE69230890 D1 DE 69230890D1 DE 69230890 T DE69230890 T DE 69230890T DE 69230890 T DE69230890 T DE 69230890T DE 69230890 D1 DE69230890 D1 DE 69230890D1
Authority
DE
Germany
Prior art keywords
matrix proteins
nuclear matrix
liquids
determination
evaluating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69230890T
Other languages
English (en)
Other versions
DE69230890T2 (de
Inventor
Anne Beausang
P Lidgard
E Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matritech Inc
Original Assignee
Matritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matritech Inc filed Critical Matritech Inc
Publication of DE69230890D1 publication Critical patent/DE69230890D1/de
Application granted granted Critical
Publication of DE69230890T2 publication Critical patent/DE69230890T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
DE69230890T 1991-10-31 1992-10-29 Bestimmung von nukleären matrixproteinen in flüssigkeiten Expired - Lifetime DE69230890T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78580491A 1991-10-31 1991-10-31
PCT/US1992/009220 WO1993009437A2 (en) 1991-10-31 1992-10-29 Nuclear matrix protein fluid assay

Publications (2)

Publication Number Publication Date
DE69230890D1 true DE69230890D1 (de) 2000-05-11
DE69230890T2 DE69230890T2 (de) 2000-12-07

Family

ID=25136671

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230890T Expired - Lifetime DE69230890T2 (de) 1991-10-31 1992-10-29 Bestimmung von nukleären matrixproteinen in flüssigkeiten

Country Status (9)

Country Link
US (8) US5965376A (de)
EP (1) EP0642668B1 (de)
JP (1) JP3190042B2 (de)
AT (1) ATE191567T1 (de)
AU (1) AU658257B2 (de)
CA (1) CA2122473C (de)
DE (1) DE69230890T2 (de)
ES (1) ES2147555T3 (de)
WO (1) WO1993009437A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2122473C (en) 1991-10-31 2001-01-23 Lee Anne Beausang Nuclear matrix protein fluid assay
ATE257513T1 (de) * 1992-06-22 2004-01-15 Matritech Inc Neuartige marker maligner zelltypen in der inneren nukleären matrix
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
CA2209314A1 (en) * 1995-11-03 1997-05-09 Robert H. Getzenberg Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
US6280956B1 (en) 1995-11-03 2001-08-28 University Of Pittsburgh Antibodies to bladder cancer nuclear matrix proteins and their use
US5914238A (en) 1996-06-05 1999-06-22 Matritech, Inc. Materials and methods for detection of breast cancer
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US6232443B1 (en) * 1997-04-08 2001-05-15 University Of Pittsburgh Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
US7229772B1 (en) 1998-03-18 2007-06-12 Roche Diagnostics Gmbh Detection of apoptotic products
EP1064549B1 (de) 1998-03-18 2006-06-07 Roche Diagnostics GmbH Nachweis von produkten von apoptosis
ATE366935T1 (de) 1999-05-17 2007-08-15 Cytyc Corp Identifizierung von material aus dem milchkanal der brust
US6617432B1 (en) * 1999-10-15 2003-09-09 University Of Pittsburgh Nuclear matrix proteins polynucleotide sequences encoding them and their use
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
KR100350111B1 (ko) 2000-02-22 2002-08-23 삼성전자 주식회사 반도체 장치의 배선 및 이의 제조 방법
US7654227B1 (en) * 2001-12-20 2010-02-02 Pat Yananton Absorbent pad for entrapping small and large particles, retaining liquids and eliminating odors
US7080373B2 (en) * 2001-03-07 2006-07-18 Freescale Semiconductor, Inc. Method and device for creating and using pre-internalized program files
US20030044352A1 (en) * 2001-04-24 2003-03-06 Phillips Nigel C. Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
JP4274856B2 (ja) * 2003-06-19 2009-06-10 オリンパス株式会社 Ｄｎａとｄｎａ結合タンパク質との反応を検出する方法
JP4425919B2 (ja) * 2003-09-23 2010-03-03 エヌエックスピー ビー ヴィ 適応フィルタ
US7649988B2 (en) 2004-06-15 2010-01-19 Acoustic Technologies, Inc. Comfort noise generator using modified Doblinger noise estimate
US7846676B2 (en) * 2004-07-19 2010-12-07 Cell Biosciences, Inc. Methods and devices for analyte detection
EP3527976A1 (de) * 2004-07-19 2019-08-21 ProteinSimple Verfahren und vorrichtungen zur analytdetektion
US7935479B2 (en) 2004-07-19 2011-05-03 Cell Biosciences, Inc. Methods and devices for analyte detection
WO2006110725A2 (en) * 2005-04-09 2006-10-19 Cell Biosciences, Inc. Automated micro-volume assay system
PT1889065E (pt) 2005-05-18 2013-09-27 Novartis Ag Métodos para o diagnóstico e tratamento de doenças tendo uma componente autoimune e/ou inflamatória
US20070015166A1 (en) * 2005-07-14 2007-01-18 Nilsen Thor W Lateral flow methods and devices for detection of nucleic acid binding proteins
WO2007035864A2 (en) 2005-09-20 2007-03-29 Cell Biosciences, Inc. Electrophoresis standards, methods and kits
US20080017512A1 (en) * 2006-07-24 2008-01-24 Bordunov Andrei V Coatings for capillaries capable of capturing analytes
WO2008057605A2 (en) * 2006-11-10 2008-05-15 Quidel Corporation Nuclear protein extraction medium and method of use
US20090023156A1 (en) * 2007-07-20 2009-01-22 Voss Karl O Methods and reagents for quantifying analytes
US10107782B2 (en) 2008-01-25 2018-10-23 ProteinSimple Method to perform limited two dimensional separation of proteins and other biologicals
JP2011206049A (ja) 2010-03-08 2011-10-20 Sumio Sugano 壊死マーカー及びその用途
EP2839276B1 (de) 2012-04-19 2018-06-27 ProteinSimple Isoelektrische fokussierung mit zwei wellenlängen zur bestimmung der wirkstofflast in antikörper-wirkstoff-konjugaten
US9766206B2 (en) 2013-09-27 2017-09-19 ProteinSimple Apparatus, systems, and methods for capillary electrophoresis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US5273877A (en) * 1985-12-24 1993-12-28 Massachusetts Institute Of Technology Non-histological cell type determination
US4882268A (en) * 1985-12-24 1989-11-21 Massachusetts Institute Of Technology Method for determining tissue of origin and degree of malignancy of tumor cells
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US4861581A (en) * 1986-12-05 1989-08-29 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
US4937185A (en) * 1987-07-31 1990-06-26 The Ohio State University Research Foundation Detection of circulating antibodies to a cancer marker protein
WO1989006697A1 (en) * 1988-01-19 1989-07-27 The University Of Sydney Detection of cell death
US5017474A (en) * 1988-02-12 1991-05-21 Eastman Kodak Company Wash solution, test kit and method for the determination of an immunological ligand
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
AU7974791A (en) * 1990-05-01 1991-11-27 Isis Pharmaceuticals, Inc. Identification of novel drugs and reagents
CA2122473C (en) * 1991-10-31 2001-01-23 Lee Anne Beausang Nuclear matrix protein fluid assay
WO1993009142A1 (en) * 1991-11-08 1993-05-13 University Of Saskatchewan Acute phase proteins for detection and prognosis of infection and tissue damage
AU4288593A (en) * 1992-04-15 1993-11-18 Brigham And Women's Hospital Method and composition for the detection of lesions
ATE257513T1 (de) * 1992-06-22 2004-01-15 Matritech Inc Neuartige marker maligner zelltypen in der inneren nukleären matrix

Also Published As

Publication number Publication date
EP0642668A1 (de) 1995-03-15
US20030096304A1 (en) 2003-05-22
JP3190042B2 (ja) 2001-07-16
US5965376A (en) 1999-10-12
ES2147555T3 (es) 2000-09-16
ATE191567T1 (de) 2000-04-15
WO1993009437A2 (en) 1993-05-13
DE69230890T2 (de) 2000-12-07
US6162608A (en) 2000-12-19
EP0642668B1 (de) 2000-04-05
AU658257B2 (en) 1995-04-06
AU3123593A (en) 1993-06-07
US5840503A (en) 1998-11-24
CA2122473A1 (en) 1993-05-13
WO1993009437A3 (en) 1993-06-10
US6410247B1 (en) 2002-06-25
CA2122473C (en) 2001-01-23
US6740494B2 (en) 2004-05-25
JPH07500671A (ja) 1995-01-19
US5989826A (en) 1999-11-23
US20050059026A1 (en) 2005-03-17
US20060127941A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
ATE191567T1 (de) Bestimmung von nukleären matrixproteinen in flüssigkeiten
ATE205602T1 (de) Verfahren und gerät zum nachweis und zur quantifizierung von glukose in körperflüssigkeiten
ATE543T1 (de) Diagnostisches mittel, verfahren zu dessen herstellung sowie dessen verwendung zum nachweis von leukozyten in koerperfluessigkeiten.
DE69110098T2 (de) Teststreifen zur visuellen Bestimmung der Blutglucosekonzentration.
IT1230178B (it) Procedimento e dispositivo per l'analisi quantitativa e differenziale in profondita' di provini solidi con l'impiego di due raggi ionici
ATE263505T1 (de) Mittels vakuum verbesserter transdermaler flüssigkeitstransport
DE59007613D1 (de) Verfahren zum Nachweis und zur Bestimmung von Humanserumalbumin in biologischen Flüssigkeiten mit Hilfe fluorogener Cyanin-Farbstoffe.
DE3882804T2 (de) Apparat zum Nachweis von bestimmten Stoffen in Urin, ein Klosett und ein System zur Sammlung von Gesundheitsinformation.
DE3880118T2 (de) Verwendung eines mittels in form von mikrokapseln zur schabenbekaempfung.
DE68925481T2 (de) Verfahren zum nachweis von bakterien im harn
DE3888998D1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten.
IT8921788A0 (it) Reattivo utile per la rilevazione e la determinazione quantitativa dei leucociti in fluidi biologici.
ES2078733T3 (es) Metodo para la deteccion de anticuerpos anti-arn.
DE69428278D1 (de) Leukozytadhaesiontest
IT8423926A0 (it) Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
DK70488D0 (da) Fremgangsmaade til paavisning af antistoffer i blod, samt membran og test-saet til anvendelse ved udoevelse af fremgangsmaaden
ES8700440A1 (es) Metodo y equipo para detectar la presencia de aminas
NO893904D0 (no) Fremgangsmaate for aa bestemme oksyderbare organiske forbindelser i et vaeske- og/eller gassmedium.
DE69023500D1 (de) Verfahren zum nachweis von antikörpern gegen streptokinase.
NO904548L (no) Paavisning, kvantifisering og klassifikasjon av ras-proteiner i kroppsfluider og -vev.
IT8867856A0 (it) Procedimento per la rivelazione di sangue occulto nelle feci
DE29819276U1 (de) Testsystem zum nicht-invasiven Nachweis von in Körperflüssigkeiten vorhandenen Antigenen oder Antikörpern
DE3890854T1 (de) Ultraschallverfahren und -vorrichtung, insbesondere zur pruefung von dichtem gewebe
ATE17789T1 (de) Verfahren zum aufspueren oder bestimmung von histamin in histaminenthaltenden materialien, insbesondere in koerperfluessigkeiten und analytischen mitteln zur verwendung in derartigem verfahren.
IT1276615B1 (it) Metodo per la rivelazione di catecolamine durante il ritmo circadiano, uso di detto metodo per la diagnosi e la terapia di malattie nervose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MATRITECH, INC. (N.D.GES.D. STAATES DELAWARE),, US

R071 Expiry of right

Ref document number: 642668

Country of ref document: EP